Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Short-Term Debt issuances Short-Term Debt repayments

Growth Metrics

Marimed (MRMD) Shares Issued (2016 - 2023)

Marimed has reported Shares Issued over the past 7 years, most recently at $74000.0 for Q3 2023.

Quarterly Shares Issued changed N/A to $74000.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $74000.0 through Dec 2024, down 32.11% year-over-year, with the annual reading at $109000.0 for FY2023, 990.0% up from the prior year.
Shares Issued was $74000.0 for Q3 2023 at Marimed, up from $35000.0 in the prior quarter.
Over five years, Shares Issued peaked at $2.6 million in Q1 2019 and troughed at -$2.6 million in Q2 2019.
The 4-year median for Shares Issued is $8000.0 (2021), against an average of $24222.1.
The largest YoY upside for Shares Issued was 333.33% in 2019 against a maximum downside of 132.91% in 2019.
A 4-year view of Shares Issued shows it stood at -$1.0 in 2019, then surged by 8400100.0% to $84000.0 in 2021, then tumbled by 96.43% to $3000.0 in 2022, then surged by 2366.67% to $74000.0 in 2023.
Per Business Quant, the three most recent readings for MRMD's Shares Issued are $74000.0 (Q3 2023), $35000.0 (Q2 2023), and $3000.0 (Q1 2022).